Abbott Laboratories (ABT)

Abbott Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	13,502	13,402	5,723	6,933	7,071	4,495
Depreciation & Amortization	3,169	3,218	3,243	3,267	3,538	3,327
Loss (Gain) From Sale of Assets	482	482	126	215	55	425
Stock-Based Compensation	658	673	644	685	640	546
Change in Accounts Receivable	-802	-691	-356	-68	-383	-924
Change in Inventory	97	-58	-232	-1,413	-456	-493
Change in Accounts Payable	356	356	-760	420	1,288	1,766
Change in Income Taxes	-8,028	-8,028	-585	-383	-908	-614
Change in Other Net Operating Assets	-484	-796	-542	-75	-312	-627
Operating Cash Flow	8,950	8,558	7,261	9,581	10,533	7,901
Operating Cash Flow Growth	25.30%	17.86%	-24.21%	-9.04%	33.31%	28.77%
Capital Expenditures	-2,293	-2,207	-2,202	-1,777	-1,885	-2,177
Cash Acquisitions	-	-	-877	-	-187	-42
Divestitures	1	1	40	48	134	58
Investment in Securities	-105	-141	-116	-33	-96	-73
Other Investing Activities	14	9	22	22	26	19
Investing Cash Flow	-2,383	-2,338	-3,133	-1,740	-2,008	-2,215
Short-Term Debt Issued	-	-	21	47	-	2
Long-Term Debt Issued	-	223	2	7	4	1,281
Total Debt Issued	224	223	23	54	4	1,283
Short-Term Debt Repaid	-	-100	-	-	-204	-
Long-Term Debt Repaid	-	-660	-2,498	-753	-48	-1,333
Total Debt Repaid	-1,670	-760	-2,498	-753	-252	-1,333
Net Debt Issued (Repaid)	-1,446	-537	-2,475	-699	-248	-50
Issuance of Common Stock	417	264	167	167	255	245
Repurchase of Common Stock	-1,349	-1,295	-1,227	-3,795	-2,299	-403
Common Dividends Paid	-3,905	-3,836	-3,556	-3,309	-3,202	-2,560
Other Financing Activities	-	-	-	-	-	-11
Financing Cash Flow	-6,283	-5,404	-7,091	-7,636	-5,494	-2,779
Foreign Exchange Rate Adjustments	-36	-96	-23	-122	-70	71
Net Cash Flow	248	720	-2,986	83	2,961	2,978
Free Cash Flow	6,657	6,351	5,059	7,804	8,648	5,724
Free Cash Flow Growth	35.22%	25.54%	-35.17%	-9.76%	51.08%	27.26%
Free Cash Flow Margin	15.72%	15.14%	12.61%	17.88%	20.08%	16.54%
Free Cash Flow Per Share	3.81	3.63	2.89	4.42	4.83	3.21
Cash Interest Paid	604	604	662	563	544	549
Cash Income Tax Paid	1,753	1,723	1,475	1,864	1,941	970
Levered Free Cash Flow	6,032	5,610	4,990	7,340	7,675	5,269
Unlevered Free Cash Flow	6,376	5,959	5,389	7,689	8,009	5,610
Change in Net Working Capital	66	410	809	182	37	-500

Updated Apr 16, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q